Dosing, drug interactions top FDA’s questions about CBD as review continues

Hemp Industry Daily
By Kristen NicholsJun 17, 2019, 3:13 pm289 pts
The regulators in charge of U.S. policy on CBD are giving the industry a first look at federal concerns as the U.S. Food and Drug Administration (FDA) starts work looking at how cannabinoids can be used in food, drugs and dietary supplements. Dr. Amy Abernethy and Lowell Schiller, who lead the FDA’s new work…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Marijuana Opponents ‘Have Lost’ The Debate, GOP Senator Says, Arguing ‘It’s Time’ To Regulate It Like Alcohol And Tobacco 65

Texas delivers potential major milestone for hemp and medical marijuana 64

Frenchman faces possible death sentence in Malaysia over cannabis charges 62

Verano Unveils Bodega-Style Dispensary Experience at Zen Leaf Cave Creek in Phoenix 56

Nova Scotians bought $127 worth of cannabis in 2024 as sales begin to level off 42

Officials send dozens of cease and desists over hemp 35

Chicago Police Can’t Search Vehicles Based on Smell of Raw Cannabis Under New Rules 32

Marijuana Industry Workers Are The Happiest In Any Job Sector In The U.S., Survey Finds 15

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.